| Effects of the SV40 large T antigen and EJ ras oncogene on fibronectin localization in human endometrial cells as viewed by confocal laser scanning microscopy. | endometrial, |
| Expression of ERas oncogene in gastric carcinoma. | gastric, |
| Epigenetic regulation of the embryonic oncogene ERas in gastric cancer cells. | gastric, |
| Loss of methylation in the promoter of ERas might be one of mechanisms responsible for the re-expression of an embryonic oncogene in gastric cancer. | gastric, |
| Fluorescent laser scanning microscopy of F-actin disruption in human endometrial stromal cells expressing the SV40 large T antigen and the EJ ras oncogene. | endometrial, |
| Identification of HLA-A*2402-restricted epitope peptide derived from ERas oncogene expressed in human scirrhous gastric cancer. | gastric, |
| Reduced hormone-stimulated adenylate cyclase activity in NIH-3T3 cells expressing the EJ human bladder ras oncogene. | bladder, |
| Development of keratoacanthomas and squamous cell carcinomas in transgenic rabbits with targeted expression of EJras oncogene in epidermis. | None |
| Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. | None |
| transforming oncogene ERas is important in the tumour-like growth properties of embryonic stem cells | None |
| Transforming growth factor beta stimulates mitogenically mouse NIH3T3 fibroblasts and those cells transformed by the EJ-H ras oncogene. | None |
| EJ-ras oncogene transfection of endothelial cells upregulates the expression of syndecan-4 and downregulates heparan sulfate sulfotransferases and epimerase. | None |
| ERas oncogene expression and epigenetic regulation by histone acetylation in human cancer cells. | None |
| Inhibition of HSV-1 multiplication in rat embryo fibroblasts constitutively expressing the EJ-ras oncogene. | None |
| Glucocorticoid dexamethasone reversibly complements EJ-RAS oncogene to transform mouse embryo BALB-3T3 cells. | None |
| Tumorigenicity of human mesothelial cell line transfected with EJ-ras oncogene. | None |
| Inhibition of adenylate cyclase and phospholipase A2/C in NIH-3T3 cells expressing the EJ-ras oncogene. | None |
| Loss of platelet-derived growth factor-stimulated phospholipase activity in NIH-3T3 cells expressing the EJ-ras oncogene. | None |
| Normal human mesothelial cells and fibroblasts transfected with the EJras oncogene become EGF-independent, but are not malignantly transformed. | None |
| Platelet-derived growth factor does not induce c-fos in NIH 3T3 cells expressing the EJ-ras oncogene. | None |